MedPath

Safety Study to Evaluate Intracranial Pressure During High Frequency Chest Wall Oscillation

Not Applicable
Terminated
Conditions
Intracranial Pressure
Registration Number
NCT00279097
Lead Sponsor
Hill-Rom
Brief Summary

The purpose of this study is to evaluate changes in intracranial pressure (ICP) during or immediately following high frequency chest wall oscillation (HFCWO) treatment with the Vest™ in neurosurgical subjects.

Detailed Description

This study is a single site safety study to evaluate changes in intracranial pressure during or immediately following HFCWO treatment with the Vest™ in neurosurgical subjects with intracranial pressure monitors having normal opening pressures and ICP less than or equal to 20 mmHg. The secondary objective of this study is to evaluate changes in arterial blood gases that may result with Vest™ therapy in ventilated patients.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • ICP monitor with normal opening pressure (greater than or equal to 20 mmHg)
  • On ventilator
  • Arterial line in place
  • Age equal to or greater than 18
  • Admitted to neurotrauma intensive care unit (ICU)
Exclusion Criteria
  • Inability to obtain informed consent
  • Unstable spinal cord injury
  • ICP > 20 mmHg sustained for > 5 minutes
  • Hemodynamic instability within the prior 12 hours
  • Active hemoptysis
  • Hemothorax
  • New onset, unstable arrhythmia
  • Enrollment in another interventional study
  • Aneurysm that has not been clipped or coiled
  • Coagulopathic head injury subjects

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Intracranial pressure
SpO2
Heart rate
Mean arterial pressure (MAP)
Arterial blood gases (ABGs)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Texas at Houston/Memorial Hermann Hospital

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath